Can Fite Biopharma Ltd ADR (CANF) — Net Asset Quality Index
Can Fite Biopharma Ltd ADR (CANF) has a Net Asset Quality Index of 58.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $9.51 Million minus total liabilities of $3.92 Million yields net assets of $5.59 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check Can Fite Biopharma Ltd ADR liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Can Fite Biopharma Ltd ADR Net Asset Quality Index Over Time (2011–2025)
This chart shows how Can Fite Biopharma Ltd ADR's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the index stands at 58.8%, representing net assets of $5.59 Million against total assets of $9.51 Million USD. See working capital position of Can Fite Biopharma Ltd ADR to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Can Fite Biopharma Ltd ADR (2011–2025)
The table below presents the year-by-year Net Asset Quality Index for Can Fite Biopharma Ltd ADR from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CANF market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 58.8% | $5.59 Million | $9.51 Million | $3.92 Million | ▼ -0.8 pp |
| 2024 | 59.6% | $5.44 Million | $9.12 Million | $3.68 Million | ▼ -2.9 pp |
| 2023 | 62.5% | $6.24 Million | $9.99 Million | $3.75 Million | ▲ +14.3 pp |
| 2022 | 48.2% | $4.47 Million | $9.28 Million | $4.81 Million | ▼ -22.8 pp |
| 2021 | 71.0% | $14.38 Million | $20.25 Million | $5.87 Million | ▲ +7.2 pp |
| 2020 | 63.8% | $6.07 Million | $9.52 Million | $3.45 Million | ▲ +33.9 pp |
| 2019 | 29.9% | $2.44 Million | $8.17 Million | $5.73 Million | ▼ -8.0 pp |
| 2018 | 37.9% | $3.02 Million | $7.95 Million | $4.94 Million | ▼ -1.1 pp |
| 2017 | 39.0% | $3.05 Million | $7.83 Million | $4.78 Million | ▲ +0.9 pp |
| 2016 | 38.1% | $3.87 Million | $10.17 Million | $6.29 Million | ▼ -21.2 pp |
| 2015 | 59.3% | $10.44 Million | $17.60 Million | $7.16 Million | ▼ -8.0 pp |
| 2014 | 67.3% | $6.86 Million | $10.19 Million | $3.33 Million | ▲ +0.1 pp |
| 2013 | 67.2% | $4.46 Million | $6.63 Million | $2.18 Million | ▲ +110.5 pp |
| 2012 | -43.3% | $-707.99K | $1.64 Million | $2.34 Million | ▼ -110.4 pp |
| 2011 | 67.1% | $3.29 Million | $4.90 Million | $1.61 Million | — |